Published on in CHOP in the Media
In this video interview, Christina Bergqvist, MD, is interviewed about the emerging role of dietary therapies, such as the ketogenic diet, as treatment options for epilepsy.
Published on in CHOP News
The New Leukodystrophy Center of Excellence will offer multidisciplinary diagnostic and clinical services for children with degenerative inherited white matter diseases, and be dedicated to advancing research for more effective treatments.
Published on in CHOP in the Media
CHOP patient Allison Reed, who is treated for pediatric multiple sclerosis, is featured on 6ABC along with Chief of Neurology, Dr. Brenda Banwell.
Published on in CHOP News
Researchers at The Children's Hospital of Philadelphia improved motor function and brain abnormalities in animals with a form of Huntington’s disease, a severe neurological disorder.
Published on in Neurosciences Update
To bridge that adult-pediatric divide, CHOP neurologist Jennifer McGuire, MD, MSCE, is conducting a pilot study to understand the neurocognitive effects of HIV in adolescents and young adults with acquired infection.
Published on in Neurosciences Update
Dr. Ana Recober, MD, is working to find out where the link between obesity and migraine headaches lies. Her goal? To help identify novel therapeutic targets for chronic migraine.
Published on in CHOP in the Media
Kids can have strokes too. Rebecca N. Ichord, MD, of CHOP's Pediatric Stroke Program, discusses the symptoms and causes of a stroke in this 6ABC segment.
Published on in Stewardship Reports
This report highlights some of the ways clinicians are providing innovative and compassionate programs for children with disorders of the brain.
Published on in CHOP in the Media
Fox 29 interviews a mother and daughter who have migraines, as well as Christina Szperka, MD, an attending neurologist, who treats children and teens at a new headache clinic.
Published on in CHOP News
Feeding amino acids to animals in a CHOP lab improved sleep disturbances caused by traumatic brain injury (TBI). This could become the first treatment for people with TBI.